IGFBP-2 DNA plasmid vaccine (Fred Hutchinson Cancer Research Center)

IGFBP-2 DNA质粒疫苗 (Fred Hutchinson Cancer Research Center)

Report date: 2026/05/22 20:01:29

Base Information

Drug NameIGFBP-2 DNA plasmid vaccine (Fred Hutchinson Cancer Research Center)
Drug Alias NameIGFBP-2 Vaccination(Fred Hutchinson Cancer Research Center)pUMVC3-hIGFBP-2 (1-163) DNA vaccine(Fred Hutchinson Cancer Research Center)IGFBP-2 N-terminus DNA plasmid vaccine(Fred Hutchinson Cancer Research Center)pUMVC3-hIGFBP-2AST-201
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research CenterAston Sci Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of WashingtonAston Sci Inc
Inactive CompaniesN/A
Active IndicationsFallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms +[4] 
Inactive IndicationsNeoplasms, Germ Cell and Embryonal

Other Information

ATC CodeN/A
Related LinksN/A